new version V2017

Linagliptin insulin secretagogues
Description Results

BI-1356 - BI1356 - BI 1356 - Tradjenta - Linagliptin      

  • Group by...

pdf
TrialStudied treatmentControl treatmentpatientsROBResultNCT

diabetes type 2

OwenslinagliptinMetformin + sulfonylurea - NCT00602472
Del Pratolinagliptinplacebo - NCT00621140
Taskinenlinagliptinplacebo (add on MET) - NCT00601250
Forst, 2010linagliptin - NCT00309608
Lewin, 2010linagliptinplacebo (add on SU) - NCT00819091
CAROLINA, 2012linagliptinglimepiride Exploratory SuggestingNCT01243424
Gallwitz, 2012linagliptinglimepiride (add on MET) - NCT00622284
CARMELINA ongoing linagliptinplacebo - NCT01897532
linagliptin 1218.62 ongoing linagliptin low doselinagliptin - NCT01012037
linagliptine 1218.50 ongoing linagliptinplacebo - NCT00740051
linagliptin1218.5 ongoing linagliptinplacebo - NCT00328172
linagliptin 1218.46 ongoing linagliptinplacebo - NCT00798161
linagliptin 1218.65 ongoing linagliptinplacebo (add on MET) - NCT01215097
linagliptin 1218.61 ongoing linagliptinplacebo (add on MET+TZD) - NCT00996658



- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons